This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ensign Group Acquires Nursing Facility to Expand in Arizona
by Zacks Equity Research
Ensign Group (ENSG) purchases the real estate and operations of Surprise Health and Rehabilitation Center to boost presence in Arizona.
Why Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Banking on its solid second-quarter results and a growing bottom line, Universal Health (UHS) holds potential to garner benefits for investors.
Tenet Healthcare's Senior Secured Notes Get Rating Actions
by Zacks Equity Research
Tenet Healthcare's (THC) new senior secured first lien notes receive rating affirmations from Moody's. Outlook is stable.
Universal Health's (UHS) Q2 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Universal Health's (UHS) second-quarter results gain from its healthy top-line growth.
Universal Health Services (UHS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 10.84% and 1.64%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
What to Expect for Universal Health's (UHS) Q2 Earnings
by Zacks Equity Research
Universal Health's (UHS) Q2 earnings are likely to gain from its strong segmental performances at Acute Care and Behavioral Health, partly offset by high costs.
Universal Health Services (UHS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare Up 30% in a Year: Will the Rally Sustain?
by Zacks Equity Research
HCA Healthcare (HCA) stock rallies on the back of increase in admissions. Also, acquisitions made by the company are driving business growth.
Universal Health's Segmental Strength Aids, High Costs Hurt
by Zacks Equity Research
Solid segmental contributions bode well for Universal Health's (UHS) growth. However, elevated expenses are a lingering concern.
Universal Health Services (UHS) Down 6.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hospital Industry Outlook: Demography, Consolidation Act As Tailwinds
by Sapna Bagaria
Hospital industry to gain from demographical changes and growing consolidation, partially offset by high labor cost.
Universal Health (UHS) Q1 Earnings, Revenues Miss Estimates
by Zacks Equity Research
Universal Health's (UHS) first-quarter earnings are affected by a pre-tax unrealized loss.
Is a Beat Likely for Universal Health (UHS) Q1 Earnings?
by Zacks Equity Research
Universal Health's (UHS) Q1 is likely to gain traction from higher admissions as well as licensed beds. However, the same might be partially offset by escalating costs.
Universal Health Services (UHS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Universal Health Services (UHS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Universal Health Services (UHS) Down 3.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HCA Healthcare's Organic & Inorganic Strategies Drive Growth
by Zacks Equity Research
A number of acquisitions, network expansion, technological investment and strong balance sheet drive growth at HCA Healthcare (HCA).
Universal Health's Acute Care Segment Solid, High Debt Ails
by Zacks Equity Research
Riding high on solid segmental performances, Universal Health (UHS) promises to reap great benefits for investors. However, its debt load bothers.
Should Value Investors Pick Universal Health (UHS) Stock?
by Zacks Equity Research
Let's see if Universal Health (UHS) stock is a good choice for value-oriented investors right now from multiple angles.
Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet
by Zacks Equity Research
Acadia Healthcare (ACHC) Q4 earnings miss, down year over year on increase in expenses.
Universal Health's (UHS) Q4 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results gain from its healthy top-line growth.
What's in Store for Universal Health (UHS) Q4 Earnings?
by Zacks Equity Research
Universal Health's (UHS) earnings in the fourth quarter are likely to gain from higher admissions and patient days.
Universal Health Services (UHS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 earnings surge on the back of operating performance and strong growth across all core businesses.
HCA Healthcare's (HCA) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings rise on the back of robust same facility admissions.
What's in the Cards for Anthem (ANTM) This Earnings Season?
by Zacks Equity Research
Anthem (ANTM) is likely to gain from Q4 results on revenue and membership growth, partly offset by higher expenses.